Protein expression profiling of normal and neoplastic canine prostate and bladder tissue

Veterinary and Comparative Oncology

Volumn 5, Issue 2, 2007, Pages 119-130

  Leroy, Bruce E ^a   Painter, A ^a   Sheppard, H ^a   Popiolek, L ^b   Samuel Foo, M ^c   Andacht, T M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Canine; Principal components analysis; Prostatic carcinoma; Proteomics; Two dimensional differential in gel electrophoresis

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 61749091562     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2006.00121.x     Document Type: Article

References (49)

1. Priester WA and McKay FW. The Occurrence of Tumors in Domestic Animals. Washington, DC, US Government Printing Office, 1980.
2. Barsanti JA. Diseases of the prostate gland. In: Canine and Feline Nephrology and Urology. CA Osborne and DR Finco, eds., Baltimore, Williams & Wilkins, 1995: 746-749.
3. Leav I and Ling GV. Adenocarcinoma of the canine prostate. Cancer 1968; 22: 1329-1345.
4. Leav I, Cavazos LF and Ofner P. Fine structure and C19-steroid metabolism of spontaneous adenocarcinoma of the canine prostate. Journal of the National Cancer Institute 1974; 52: 789-804.
5. Huggins CB and Clark PJ. Quantitative studies of prostatic secretion. II. The effect of castration and of estrogen injection on the hyperplastic prostate glands of dogs. The Journal of Experimental Medicine 1940; 72: 747-750.
6. Cornell KK, Bostwick DG, Cooley DM, Hall G, Harvey HJ, Hendrick MJ, Pauli BU, Render JA, Stoica G, Sweet DC and Waters DJ. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases. The Prostate 2000; 45: 173-183.
7. Kennedy PC, Cullen JM, Edwards JF, Goldschmidt MH, Larsen S, Munson L and Nielsen S. Histological Classification of Tumors of the Genital System of Domestic Animals. Washington, DC, Armed Forces Institute of Pathology, 1998.
8. LeRoy BE, Nadella MV, Toribio RE, Leav I and Rosol TJ. Canine prostate carcinomas express markers of urothelial and prostatic differentiation. Veterinary Pathology 2004; 41: 131-140.
9. Sorenmo KU, Goldschmidt M, Shofer F, Goldkamp C and Ferracone J. Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time. Veterinary and Comparative Oncology 2003; 1: 48-56.
10. Leav I, Schelling KH, Adams JY, Merk FB and Alroy J. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. The Prostate 2001; 48: 210-224.
11. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC and Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-577.
12. Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGarvey K, Knowlton M, Chen S, Shu H, Sahin A, Kurek R, Wallwiener D, Merino MJ, Petricoin EF III, Zhao Y and Steeg PS. Proteomics of human breast ductal carcinoma in situ. Cancer Research 2002; 62: 6740-6749.
13. Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR, Emmert-Buck MR, Liotta LA, Petricoin EF III and Zhao Y. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Molecular & Cellular Proteomics 2002; 1: 117-124.
14. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO and Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
15. Simpson RJ. Protein and Proteomics. New York, Cold Spring Harbor Laboratory Press, 2003.
16. Kleno TG, Leonardsen LR, Kjeldal HO, Laursen SM, Jensen ON and Baunsgaard D. Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysis. Proteomics 2004; 4: 868-880.
17. Quinn GP and Keough MJ. Principal Components and Correspondence Analysis. Experimental Design and Data Analysis for Biologists. Cambridge, Cambridge Press, 2002.
18. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L and Depinho RA. High-resolution genomic profiles of human lung cancer. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 9625-9630.
19. Meehan KL, Holland JW and Dawkins HJ. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. The Prostate 2002; 50: 54-63.
20. Kim J, Kim SH, Lee SU, Ha GH, Kang DG, Ha NY, Ahn JS, Cho HY, Kang SJ, Lee YJ, Hong SC, Ha WS, Bae JM, Lee CW and Kim JW. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 2002; 23: 4142-4156.
21. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC and Weinberg RA. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes & Development 2001; 15: 50-65.
22. Gulmann C, Espina V, Petricoin E III, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA and Feldman AL. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clinical Cancer Research 2005; 11: 5847-5855.
23. Parent R and Beretta L. Proteomics in the study of liver pathology. Journal of Hepatology 2005; 43: 177-183.
24. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM and Carbone DP. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003; 362: 433-439.
25. Johnson MD, Floyd JL and Caprioli RM. Proteomics in diagnostic neuropathology. Journal of Neuropathology and Experimental Neurology 2006; 65: 837-845.
26. Chaurand P, Sanders ME, Jensen RA and Caprioli RM. Proteomics in diagnostic pathology: Profiling and imaging proteins directly in tissue sections. American Journal of Pathology 2004; 165: 1057-1068.
27. Petricoin EF, Zoon KC, Kohn EC, Barrett JC and Liotta LA. Clinical proteomics: Translating benchside promise into bedside reality. Nature Reviews Drug Discovery 2002; 1: 683-695.
28. Liu H, Lin D and Yates JR III. Multidimensional separations for protein/ peptide analysis in the post-genomic era. Biotechniques 2002; 32: 898, 900, 902.
29. Lebioda L and Stec B. Mapping of isozymic differences in enolase. International Journal of Biological Macromolecules 1991; 13: 97-100.
30. Pancholi V. Multifunctional alpha-enolase: Its role in diseases. Cellular and Molecular Life Sciences 2001; 58: 902-920.
31. Rehman I, Azzouzi AR, Catto JW, Allen S, Cross SS, Feeley K, Meuth M and Hamdy FC. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: A pilot study. Urology 2004; 64: 1238-1243.
32. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Nishisaka T, Okita K, Oka M and Nakamura K. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysis. Proteomics 2005; 5: 1686-1692.
33. Qi Y, Chiu JF, Wang L, Kwong DL and He QY. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005; 5: 2960-2971.
34. Osborn M and Weber K. Tumor diagnosis by intermediate filament typing: A novel tool for surgical pathology. Laboratory Investigation 1983; 48: 372-394.
35. Tarin D, Thompson EW and Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research 2005; 65: 5996-6000.
36. Thompson EW, Newgreen DF and Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Research 2005; 65: 5991-5995.
37. Demir AY, Groothuis PG, Dunselman GA, Schurgers L, Evers JL and de Goeij AF. Molecular characterization of soluble factors from human menstrual effluent that induce epithelial to mesenchymal transitions in mesothelial cells. Cell and Tissue Research 2005; 322: 299-311.
38. Koch G, Smith M, Macer D, Webster P and Mortara R. Endoplasmic reticulum contains a common, abundant calcium-binding glycoprotein, endoplasmin. Journal of Cell Science 1986; 86: 217-232.
39. Lee AS. The glucose-regulated proteins: Stress induction and clinical applications. Trends in Biochemical Sciences 2001; 26: 504-510.
40. Reddy RK, Lu J and Lee AS. The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis. The Journal of Biological Chemistry 1999; 274: 28476-28483.
41. Reddy RK, Dubeau L, Kleiner H, Parr T, Nichols P, Ko B, Dong D, Ko H, Mao C, DiGiovanni J and Lee AS. Cancer-inducible transgene expression by the GRP94 promoter: Spontaneous activation in tumors of various origins and cancer-associated macrophages. Cancer Research 2002; 62: 7207-7212.
42. Sherwood ER, Berg LA, Mitchell NJ, McNeal JE, Kozlowski JM and Lee C. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. The Journal of Urology 1990; 143: 167-171.
43. Sherwood ER, Theyer G, Steiner G, Berg LA, Kozlowski JM and Lee C. Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate. The Prostate 1991; 18: 303-314.
44. Bassily NH, Vallorosi CJ, Akdas G, Montie JE and Rubin MA. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. American Journal of Clinical Pathology 2000; 113: 383-388.
45. Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, Billingham LJ, Ismail T, Wakelam MJ, Johnson PJ and Martin A. Identification of serum biomarkers for colon cancer by proteomic analysis. British Journal of Cancer 2006; 94: 1898-1905.
46. Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S and Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005; 5: 4589-4596.
47. Byrjalsen I, Mose LP, Fey SJ, Nilas L, Larsen MR and Christiansen C. Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma. Molecular Human Reproduction 1999; 5: 748-756.
48. Alaiya A, Al Mohanna M and Linder S. Clinical cancer proteomics: promises and pitfalls. Journal of Proteome Research 2005; 4: 1213-1222.
49. Tannock IF and Hill RP. The Basic Science of Oncology. New York, McGraw-Hill, 1998.